IκBζ regulates TH17 development by cooperating with ROR nuclear receptors

被引:0
|
作者
Kazuo Okamoto
Yoshiko Iwai
Masatsugu Oh-hora
Masahiro Yamamoto
Tomohiro Morio
Kazuhiro Aoki
Keiichi Ohya
Anton M. Jetten
Shizuo Akira
Tatsushi Muta
Hiroshi Takayanagi
机构
[1] Graduate School of Medical and Dental Sciences,Department of Cell Signaling
[2] Tokyo Medical and Dental University,Department of Microbiology and Immunology
[3] Global Center of Excellence (GCOE) Program,Department of Pediatrics and Developmental Biology
[4] International Research Center for Molecular Science in Tooth and Bone Diseases,Department of Hard Tissue Engineering (Pharmacology)
[5] ,Division of Intramural Research
[6] Japan Science and Technology Agency (JST),undefined
[7] ERATO,undefined
[8] Takayanagi Osteonetwork Project,undefined
[9] Yushima 1-5-45,undefined
[10] Bunkyo-ku,undefined
[11] Tokyo 113-8549,undefined
[12] Japan ,undefined
[13] Medical Top Track Program,undefined
[14] Medical Research Institute,undefined
[15] Tokyo Medical and Dental University,undefined
[16] Yushima 1-5-45,undefined
[17] Bunkyo-ku,undefined
[18] Tokyo 113-8510,undefined
[19] Japan ,undefined
[20] Laboratory of Immune Regulation,undefined
[21] Graduate School of Medicine,undefined
[22] and WPI Immunology Frontier Research Center,undefined
[23] Osaka University,undefined
[24] 2-2,undefined
[25] Yamada-oka,undefined
[26] Suita,undefined
[27] Osaka 565-0871,undefined
[28] Japan,undefined
[29] Graduate School of Medical and Dental Sciences,undefined
[30] Tokyo Medical and Dental University,undefined
[31] Yushima 1-5-45,undefined
[32] Bunkyo-ku,undefined
[33] Tokyo 113-8519,undefined
[34] Japan,undefined
[35] Graduate School of Medical and Dental Sciences,undefined
[36] Tokyo Medical and Dental University,undefined
[37] Yushima 1-5-45,undefined
[38] Bunkyo-ku,undefined
[39] Tokyo 113-8549,undefined
[40] Japan,undefined
[41] Cell Biology Section,undefined
[42] National Institute of Environmental Health Sciences,undefined
[43] National Institutes of Health,undefined
[44] 111 T.W. Alexander Drive Research Triangle Park,undefined
[45] North Carolina 27709,undefined
[46] USA,undefined
[47] Laboratory of Host Defense,undefined
[48] WPI Immunology Frontier Research Center,undefined
[49] Osaka University,undefined
[50] Yamada-oka 3-1,undefined
来源
Nature | 2010年 / 464卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
The development of interleukin (IL)-17-producing T cells (TH17 cells) is shown to require the transcription factor IκBζ in addition to ROR nuclear receptors. IκBζ cooperates with ROR factors through binding to the upstream conserved non-coding sequence CNS2, and mice deficient for IκBζ are resistant to the induction of experimental autoimmune encephalomyelitis. The work highlights the transcriptional mechanisms involved in TH17 development and suggests novel therapeutic approaches to autoimmune disease.
引用
收藏
页码:1381 / 1385
页数:4
相关论文
共 50 条
  • [1] IκBζ regulates TH17 development by cooperating with ROR nuclear receptors
    Okamoto, Kazuo
    Iwai, Yoshiko
    Oh-hora, Masatsugu
    Yamamoto, Masahiro
    Morio, Tomohiro
    Aoki, Kazuhiro
    Ohya, Keiichi
    Jetten, Anton M.
    Akira, Shizuo
    Muta, Tatsushi
    Takayanagi, Hiroshi
    NATURE, 2010, 464 (7293) : 1381 - U13
  • [2] Sumoylation of RORγt regulates TH17 differentiation and thymocyte development
    He, Zhiheng
    Zhang, Jing
    Huang, Zhaofeng
    Du, Qian
    Li, Ning
    Zhang, Qiang
    Chen, Yuan
    Sun, Zuoming
    NATURE COMMUNICATIONS, 2018, 9
  • [3] Sumoylation of RORγt regulates TH17 differentiation and thymocyte development
    Zhiheng He
    Jing Zhang
    Zhaofeng Huang
    Qian Du
    Ning Li
    Qiang Zhang
    Yuan Chen
    Zuoming Sun
    Nature Communications, 9
  • [4] Genetic and pharmacological inhibition of the nuclear receptor RORα regulates TH17 driven inflammatory disorders
    Wang, Ran
    Campbell, Sean
    Amir, Mohammed
    Mosure, Sarah A.
    Bassette, Molly A.
    Eliason, Amber
    Sundrud, Mark S.
    Kamenecka, Theodore M.
    Solt, Laura A.
    NATURE COMMUNICATIONS, 2021, 12 (01)
  • [5] Genetic and pharmacological inhibition of the nuclear receptor RORα regulates TH17 driven inflammatory disorders
    Ran Wang
    Sean Campbell
    Mohammed Amir
    Sarah A. Mosure
    Molly A. Bassette
    Amber Eliason
    Mark S. Sundrud
    Theodore M. Kamenecka
    Laura A. Solt
    Nature Communications, 12
  • [6] ROR blockers inhibit TH17 cells
    Iley Ozerlat
    Nature Reviews Neurology, 2011, 7 (6) : 303 - 303
  • [7] An essential role of IκBζ in the transcriptional program in Th17 development
    Okamoto, Kazuo
    Oh-hora, Masatsugu
    Takayanagi, Hiroshi
    ARTHRITIS RESEARCH & THERAPY, 2012, 14
  • [8] An essential role of IκBζ in the transcriptional program in Th17 development
    Kazuo Okamoto
    Masatsugu Oh-hora
    Hiroshi Takayanagi
    Arthritis Research & Therapy, 14 (Suppl 1):
  • [9] RORγt and RORα signature genes in human Th17 cells
    Castro, Glenda
    Liu, Xuejun
    Ngo, Karen
    De Leon-Tabaldo, Aimee
    Zhao, Shanrong
    Luna-Roman, Rosa
    Yu, Jingxue
    Cao, Tinghua
    Kuhn, Robert
    Wilkinson, Patrick
    Herman, Krystal
    Nelen, Marina I.
    Blevitt, Jonathan
    Xue, Xiaohua
    Fourie, Anne
    Fung-Leung, Wai-Ping
    PLOS ONE, 2017, 12 (08):
  • [10] Nuclear receptors: TH17 cell control from within
    Klotz, L.
    Knolle, P.
    FEBS LETTERS, 2011, 585 (23): : 3764 - 3769